- Home
- VERB vs NLSP Comparison
VERB vs NLSP Comparison
Compare VERB & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERB
- NLSP
- Stock Information
- Founded
- VERB 2014
- NLSP 2015
- Country
- VERB United States
- NLSP Switzerland
- Employees
- VERB N/A
- NLSP N/A
- Industry
- VERB Other Consumer Services
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- VERB Consumer Discretionary
- NLSP Health Care
- Exchange
- VERB Nasdaq
- NLSP Nasdaq
- Market Cap
- VERB 4.7M
- NLSP 5.2M
- IPO Year
- VERB N/A
- NLSP 2021
- Fundamental
- Price
- VERB $6.01
- NLSP $1.85
- Analyst Decision
- VERB Strong Buy
- NLSP
- Analyst Count
- VERB 1
- NLSP 0
- Target Price
- VERB $100.00
- NLSP N/A
- AVG Volume (30 Days)
- VERB 93.4K
- NLSP 440.1K
- Earning Date
- VERB 11-05-2024
- NLSP 12-31-2024
- Dividend Yield
- VERB N/A
- NLSP N/A
- EPS Growth
- VERB N/A
- NLSP N/A
- EPS
- VERB N/A
- NLSP N/A
- Revenue
- VERB $201,000.00
- NLSP N/A
- Revenue This Year
- VERB $547.62
- NLSP N/A
- Revenue Next Year
- VERB $200.00
- NLSP N/A
- P/E Ratio
- VERB N/A
- NLSP N/A
- Revenue Growth
- VERB 415.38
- NLSP N/A
- 52 Week Low
- VERB $5.05
- NLSP $1.75
- 52 Week High
- VERB $184.60
- NLSP $24.32
- Technical
- Relative Strength Index (RSI)
- VERB 35.34
- NLSP 22.65
- Support Level
- VERB $5.81
- NLSP $1.75
- Resistance Level
- VERB $8.31
- NLSP $2.13
- Average True Range (ATR)
- VERB 0.77
- NLSP 0.29
- MACD
- VERB -0.18
- NLSP -0.03
- Stochastic Oscillator
- VERB 12.46
- NLSP 4.23
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.